Researchers
Discover all researchers in life sciences
Loading researchers...
Faizan Ahmad
Researcher at Research Department
Alzheimer'S Disease Research And Treatments
Artificial Intelligence
Cholinesterase And Neurodegenerative Diseases
Drug Discovery
Fungal Biology And Applications
471
Citations
9
H-index
0
Patents
29
Publications
0
Grants
$0
Total Funding
AI Research AssistantBeta
Ask questions about Faizan Ahmad's research, publications, and ongoing work
What are their main research contributions?
Show me their collaboration network
What grants fund their research?
Research Contributions
Identified Lupenone as a Potential Fusion Inhibitor Against Semliki Forest Virus
Utilized computational methods to identify Lupenone, a natural product, as a potential fusion inhibitor against the spike complex of Semliki Forest Virus, offering insights into antiviral drug development.
PLoS ONE (2022)
Explored the Role of Circadian Dysfunction in Alzheimer's Disease
Provided an updated review on the link between circadian dysfunction and Alzheimer's disease, highlighting potential therapeutic targets related to circadian rhythm regulation.
Aging Medicine (2022)
Investigated Ketamine as a Therapeutic Agent for Depression and PTSD
Evaluated the potential medicinal and deleterious effects of ketamine in treating major depressive disorder and posttraumatic stress disorder, contributing to the understanding of its clinical applications.
Ibrain (2023)
Examined Evolving Therapeutic Interventions for Alzheimer's Disease
Reviewed the evolving therapeutic landscape for managing and treating Alzheimer's disease, providing insights into current and future treatment strategies.
Ageing Research Reviews (2024)
Evaluated Stem Cell Therapy for Alzheimer's Disease
Consolidated a review on stem cell therapy as a potential treatment and management strategy for Alzheimer's disease, assessing its efficacy and limitations.
Aging Medicine (2022)
Identified Potential Neuroprotective Compound from Ganoderma lucidum
Identified a potential neuroprotective compound from Ganoderma lucidum extract targeting microtubule affinity regulation kinase 4 (MARK4) involved in Alzheimer's disease through molecular dynamics simulation.
Aging Medicine (2022)
Explored Non-Pharmacological Approaches to Manage Autism Spectrum Disorder
Reviewed a spectrum of non-pharmacological interventions for managing Autism Spectrum Disorder, providing insights into alternative and complementary therapies.
Medicina (2023)
Identified Dioxinodehydroeckol as a Potential Neuroprotective Marine Compound
Identified Dioxinodehydroeckol as a potential neuroprotective marine compound for the treatment and management of multiple brain disorders using in silico screening.
Molecular Biotechnology (2022)
Research Highlights
Faizan Ahmad is an expert in computational biology and drug discovery, focusing on neurodegenerative diseases like Alzheimer's and Parkinson's, utilizing computational methods to identify potential therapeutic interventions. His research also extends to understanding the molecular mechanisms of neurological disorders and exploring natural products for therapeutic applications.
Research Areas
Alzheimer'S Disease Research And TreatmentsArtificial IntelligenceCholinesterase And Neurodegenerative DiseasesDrug DiscoveryFungal Biology And Applications
Similar Researchers You Should Know
Researchers with overlapping expertise and complementary work
Finding similar researchers...